Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Liver Cirrhosis |
Free Subscription
1 Am J Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human
Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis.
Am J Pathol. 2023 Dec 28:S0002-9440(23)00484.
PubMed
Abstract available
Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the
incidence and risk factors of hepatic steatosis and hepatic fibrosis in the
Chinese population.
Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
PubMed
Serum biomarker signature is predictive of the risk of hepatocellular cancer in
patients with cirrhosis.
Gut. 2024 Feb 16:gutjnl-2024-332034. doi: 10.1136/gutjnl-2024-332034.
PubMed
Abstract available
Lack of complete biochemical response in autoimmune hepatitis leads to adverse
outcome: first report of the IAIHG retrospective registry.
Hepatology. 2023 Sep 4. doi: 10.1097/HEP.0000000000000589.
PubMed
Abstract available
National prevalence estimates for steatotic liver disease and subclassifications
using consensus nomenclature.
Hepatology. 2024;79:666-673.
PubMed
Abstract available
Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an
LDH-A/HIF-1alpha transcriptional complex.
Hepatology. 2024;79:606-623.
PubMed
Abstract available
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised
individual patient data meta-analysis.
Hepatology. 2024;79:624-635.
PubMed
Abstract available
Unlocking the immune microenvironment of non-alcoholic steatohepatitis-associated
hepatocellular carcinoma.
Hepatology. 2023 Oct 9. doi: 10.1097/HEP.0000000000000626.
PubMed
Reply to 'liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus".
Hepatology. 2024 Feb 16. doi: 10.1097/HEP.0000000000000792.
PubMed
A modified hospital frailty risk score for patients with cirrhosis undergoing
abdominal operations.
Hepatology. 2024 Feb 19. doi: 10.1097/HEP.0000000000000794.
PubMed
Abstract available
ASK1/p38 axis inhibition blocks the release of mitochondrial "danger signals"
from hepatocytes and suppresses progression to cirrhosis and liver cancer.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000801.
PubMed
Abstract available
Impending hepatocellular carcinoma diagnosis in cirrhotic patients after HCV cure
features a natural killer cell signature.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000804.
PubMed
Abstract available
Full adherence to cirrhosis quality indicators is associated with lower mortality
in acute variceal bleeding: Nationwide audit.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000793.
PubMed
Abstract available
Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis
progression and resolution in mice.
J Hepatol. 2024;80:482-494.
PubMed
Abstract available
Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte
signaling module.
J Hepatol. 2024;80:467-481.
PubMed
Abstract available
Reply to: "Comment on 'TIPS prevents further decompensation and improves survival
in patients with cirrhosis and portal hypertension in an individual patient data
meta-analysis'": Further decompensation should now be used as a clinically
relevant outc
J Hepatol. 2024;80:e109-e110.
PubMed
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
PubMed
Abstract available
Thank you for your interest in scientific medicine.